Huron Consulting Group Inc. — Q1 2024 Form 10-Q Summary
Business Context and Reporting Period
Huron is a global professional services firm providing consulting, managed services, digital, technology, data and analytics solutions. Operations are organized into Healthcare, Education and Commercial segments. This unaudited filing covers the three months ended March 31, 2024, compared with the three months ended March 31, 2023.
Key Financial Metrics
| Metric | Q1 2024 | Q1 2023 | Change |
|---|---|---|---|
| Revenue | $356.0 million | $317.9 million | 12.0% increase |
| Total revenue and reimbursable expenses | $363.4 million | $326.4 million | 11.3% increase |
| Operating income | $19.9 million | $18.4 million | 8.1% increase |
| Operating margin | 5.6% | 5.8% | Down 0.2 percentage points |
| Net income | $18.0 million | $13.4 million | 34.2% increase |
| Diluted EPS | $0.95 | $0.68 | 39.7% increase |
| Adjusted EBITDA | $33.8 million | $29.5 million | 14.6% increase |
| Adjusted EBITDA margin | 9.5% | 9.3% | Up 0.2 percentage points |
| Adjusted diluted EPS | $1.23 | $0.87 | 41.4% increase |
Healthcare revenue increased 21.3% to $180.7 million, Education revenue increased 7.1% to $111.6 million, and Commercial revenue decreased 1.6% to $63.6 million. Consulting and Managed Services revenue increased 13.8%, while Digital revenue increased 9.7%.
Healthcare segment margin improved to 23.6% from 21.6%. Education segment margin declined to 19.7% from 22.2%, while Commercial segment margin increased to 22.1% from 21.7%.
Net income benefited significantly from a discrete share-based compensation tax benefit. The effective tax rate was negative 2.5%, compared with 15.3% in the prior-year quarter.
Liquidity, Cash Flow and Debt
- Cash and cash equivalents were $18.6 million at March 31, 2024, compared with $12.1 million at December 31, 2023.
- Operating cash flow was negative $130.7 million, compared with negative $92.1 million in Q1 2023. The outflow primarily reflected annual performance bonus payments, salary-related payments and higher selling, general and administrative spending.
- Investing cash flow was negative $30.6 million, including $21.2 million for business acquisitions and $7.6 million for internally developed software.
- Financing cash flow was positive $167.9 million, reflecting net borrowings, partially offset by $61.0 million of settled share repurchases, $20.9 million of share reacquisitions for employee tax withholding and $1.4 million of debt issuance costs.
- Total borrowings were $574.0 million at March 31, 2024, consisting of $299.0 million under the revolving facility and $275.0 million under a new term loan. Total borrowings were $324.0 million at December 31, 2023.
- The credit facilities mature on November 15, 2027. Revolver availability was $300.4 million, after borrowings and letters of credit.
- The weighted average borrowing rate was 5.4%, compared with 4.2% at December 31, 2023. The Consolidated Leverage Ratio was 2.74 to 1.00 versus a covenant maximum of 3.75 to 1.00, and the Interest Coverage Ratio was 10.65 to 1.00 versus a minimum of 3.00 to 1.00.
- Management stated that available cash, internally generated liquidity and borrowing capacity are expected to support current financing needs and the long-term growth strategy.
Material Changes Versus the Prior Comparable Period
- Revenue growth was led by Healthcare demand, particularly performance improvement, strategy, financial advisory, technology and analytics services.
- Revenue-generating professionals increased 15.8% to 5,803. Consulting utilization declined to 70.2% from 76.3%, while Digital utilization increased to 74.3% from 71.0%.
- Operating expenses increased 11.5%. Direct costs increased 10.9%, but declined as a percentage of revenue to 71.2% from 71.9%. Selling, general and administrative expenses rose 19.2% to $74.3 million, driven partly by higher legal and practice administration expenses.
- Operating margin contracted despite higher operating income because corporate and selling, general and administrative expenses grew faster than revenue.
- Huron established the $275.0 million term loan in February 2024 and used the proceeds to reduce revolving debt; total debt nevertheless increased by $250.0 million from year-end.
- Huron completed acquisitions of the Vlamis data analytics services team and GG+A, a philanthropic management consulting firm. GG+A contributed approximately $1.3 million of Q1 revenue and approximately 70 employees; its purchase accounting remains preliminary in certain areas.
- Huron repurchased 624,698 shares for $62.3 million. $24.0 million remained available under the $400 million repurchase authorization, which runs through December 31, 2024.
Outlook, Commentary, Risks and Unusual Items
Management emphasized growth in Healthcare and Education, expansion of Digital capabilities, operating margin expansion and strategic capital deployment. The filing does not provide clear consolidated revenue or earnings guidance for fiscal 2024.
Management estimates 2024 purchases of property and equipment and software development will total approximately $35 million to $40 million. Remaining performance obligations under engagements with original expected durations longer than one year were $221.3 million at March 31, 2024; $65.7 million was expected to be recognized in 2024, subject to changes in work timing and variable consideration.
- Q1 restructuring charges were $2.3 million, including $1.0 million of severance, $0.8 million of non-cash lease impairment and $0.5 million of rent and related costs for vacated office space.
- Transaction-related expenses were $1.5 million, and other losses included a $1.6 million change in the fair value of acquisition-related contingent consideration and other items.
- The Shorelight convertible debt investment was carried at $66.1 million, down from $68.0 million at year-end, with the unrealized loss recorded in other comprehensive income. This valuation uses significant unobservable assumptions.
- Interest-rate exposure increased with higher debt. Management estimates that a hypothetical 100-basis-point interest-rate change would affect annualized pretax income by approximately $2.7 million, after hedging.
- Key risks include utilization and billing-rate pressure, demand volatility, dependence on client renewals and qualified personnel, technology and cybersecurity risks, acquisition integration, goodwill impairment, tax matters and general market conditions.
- Management reported no litigation or claim that it currently expects to have a material adverse effect, although legal outcomes remain uncertain. The filing also states that there were no material off-balance-sheet arrangements.
Investor Verification Checklist
- Verify whether Healthcare growth and Education demand continue to offset Commercial weakness.
- Monitor consulting utilization, headcount growth and compensation costs for their effect on margins.
- Assess the sustainability of cash generation after annual bonus payments, acquisitions, software investment and share repurchases.
- Track leverage, interest expense, borrowing rates and compliance with the credit agreement covenants.
- Review the integration and performance of GG+A and Vlamis, including changes to preliminary acquisition accounting.
- Separate recurring operating performance from the unusually favorable Q1 tax benefit and non-GAAP adjustments.
- Evaluate the valuation risk of the Shorelight investment and the potential effect of fair-value changes on comprehensive income and equity.